Year Founded
2012
Ownership
Private
Employees
~50
Stage
Phase 1
Modalities
Antibody-drug conjugate (ADC)Protein therapeuticsAntibody-drug conjugate (ADC)

Dac Biotech General Information

Company has 20 ADC drugs in total, with 5 under clinical development. Has established partnerships with Janssen and other companies.

Contact Information

Website
Primary Industry
[ "Biotech" ]
Corporate Office
Hangzhou, Zhejiang
China

Drug Pipeline

No pipeline data available

For full access to Dac Biotech's pipeline data

Book a demo

Key Partnerships

Janssen, WuXi Biologics, Aadi Bioscience

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Dac Biotech Funding

Deal TypeDateAmountStatusStage
Later Stage VCMay 12, 2021$154.9MCompletedPhase 1
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Dac Biotech's complete valuation and funding history, request access »

Dac Biotech Investors

CDG Capital
Investor Type: Venture Capital
Holding: Minority
Hillhouse Capital Management
Investor Type: Venture Capital
Holding: Minority
K. Wah Group
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 5 investors. Get the full list »